Mirati Therapeutics Inc

This powerful committee controls taxation, trade, and entitlement spending, including Medicare drug pricing and corporate tax policy, all of which directly and profoundly impact the profitability and market valuation of pharmaceutical companies.

This committee directly regulates the FDA, which approves new drugs, and oversees the NIH, a primary source of biomedical research funding, making it profoundly influential for pharmaceutical companies.

This committee's oversight of antitrust laws (relevant for mergers and acquisitions) and, critically, intellectual property (patents) directly impacts the core business model and profitability of pharmaceutical companies like Mirati.

Hearings on drug pricing and access for older Americans create significant headline risk and potential for legislative action impacting pharmaceutical companies, directly affecting Mirati's valuation and market strategy.